Similar articles

• HAART-associated body habitus and metabolic changes, Part 2.

  Liss M, Boyle BA. Liss M, et al. AIDS Read. 2000 Dec;10(12):688-91. AIDS Read. 2000. PMID: 11189733 Review. No abstract available.
• HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.

  Moyle G, Carr A. Moyle G, et al. HIV Clin Trials. 2002 Jan-Feb;3(1):89-98. HIV Clin Trials. 2002. PMID: 11894812 Review. No abstract available.
• Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.

  Young J, Rickenbach M, Weber R, Furrer H, Bernasconi E, Hirschel B, Tarr PE, Vernazza P, Battegay M, Bucher HC. Young J, et al. Antivir Ther. 2005;10(1):73-81. Antivir Ther. 2005. PMID: 15751765
• Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.

  Bongiovanni M, Fausto A, Cicconi P, Aliprandi A, Cornalba G, Bini T, Sardanelli F, D'Arminio Monforte A. Bongiovanni M, et al. J Antimicrob Chemother. 2006 Aug;58(2):485-6. doi: 10.1093/jac/dkl229. Epub 2006 Jun 2. J Antimicrob Chemother. 2006. PMID: 16751202 No abstract available.
• Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.

  Maia BS, Engelson ES, Wang J, Kotler DP. Maia BS, et al. Clin Nutr. 2005 Dec;24(6):971-8. doi: 10.1016/j.clnu.2005.06.012. Epub 2005 Aug 10. Clin Nutr. 2005. PMID: 16095765